708 filings
Page 9 of 36
4
w8g 8gq1ggt
24 May 22
KEMPHARM / TAMARA A SEYMOUR ownership change
8:58pm
4
i6jc 54ccsmrmwk
18 May 22
KEMPHARM / Matthew R Plooster ownership change
7:01pm
4
ou0pp5rtzw
18 May 22
KEMPHARM / Richard W Pascoe ownership change
5:25pm
4
drxae2th1aaha
18 May 22
KEMPHARM / R. LaDuane Clifton ownership change
5:17pm
8-K
cgoi9 zskvz
16 May 22
KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline
8:40am
DEFA14A
ktiu89 tjvl4r2
12 May 22
Additional proxy soliciting materials
5:26pm
8-K
3vlwy8mdjdf0nxs oy
12 May 22
KemPharm Reports First Quarter 2022 Financial Results and Corporate Updates
4:48pm
8-K
mi8nwce0uwi0esz3zemp
30 Mar 22
KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
4:36pm
8-K
jk28e
21 Mar 22
KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
8:49am
8-K
uxgo0yah0dnsaa
16 Mar 22
KemPharm team provided development and regulatory services to Corium pursuant to a master development services agreement
8:32am
8-K
71y5 ns6gp
22 Feb 22
Regulation FD Disclosure
9:09am
SC 13G
sel0r5sokw6ox
4 Feb 22
KEMPHARM / BlackRock ownership change
4:12pm
4
uuwxjeow5a1rkcemq
3 Feb 22
KEMPHARM / Timothy J. Sangiovanni ownership change
5:17pm
4
wythh3qov15e ut
3 Feb 22
KEMPHARM / Sven Guenther ownership change
5:17pm
4
9utve45e
3 Feb 22
KEMPHARM / R. LaDuane Clifton ownership change
5:15pm
4
chvsgy7h
3 Feb 22
KEMPHARM / Richard W Pascoe ownership change
5:14pm
4
gf79stig
3 Feb 22
KEMPHARM / Travis C Mickle ownership change
5:12pm